Cognitive-behavioral Therapy vs. Nutrition Counseling for Avoidant/Restrictive Food Intake Disorder
COUNTERACT
Cognitive and Neural Mechanisms of Cognitive-behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
1 other identifier
interventional
53
1 country
1
Brief Summary
This study is a randomized controlledlinical trial, assessing the efficacy of cognitive- behavioral therapy (CBT-AR) and nutrition counseling for avoidant/restrictive food intake disorder (ARFID) for children and adolescents (ages 10-18 years).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2023
CompletedFirst Posted
Study publicly available on registry
July 20, 2023
CompletedStudy Start
First participant enrolled
January 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2026
CompletedMay 5, 2026
April 1, 2026
2.2 years
July 5, 2023
April 29, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Food Neophobia Scale
Validated 6-item version of the Food Neophobia Scale used to assess food neophobia on a scale from 1 to 7, with higher scores indicating higher levels of food neophobia. The lowest score possible is 7, indicating low food neophobia, and highest score possible is 42, indicating high food neophobia.
Change from baseline food neophobia measured at pre-treatment to after each weekly session of treatment and after the complete 15 weeks of treatment measured at post-treatment
Functional magnetic resonance imaging (fMRI) food cue paradigm
Used to measure neural activation in response to food cues. Higher scores indicate higher neural activation. There is no minimum or maximum for this measure.
Change from baseline neural activation in response to food cues measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
Secondary Outcomes (5)
General Nutrition Knowledge Questionnaire (GNKQ)
Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
Pica, ARFID, and Rumination Disorder Interview (PARDI)
Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
Pica, ARFID, and Rumination Disorder ARFID Questionnaire (PARDI-AR-Q)
Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
4-Day Food Record measuring percent of calories consumed from fruits, vegetables, proteins, grains, and dairy food groups.
Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
24-Hour Recall measuring percent of calories consumed from fruits, vegetables, proteins, grains, and dairy food groups.
Change from baseline measured at pre-treatment to after 15 weeks of treatment measured at post-treatment
Study Arms (2)
CBT-AR
EXPERIMENTALSee intervention description
Nutrition Counseling
EXPERIMENTALSee intervention description
Interventions
Nutrition counseling will be provided by skilled registered dietitians at the MGH Translational and Clinical Research Center (TCRC). Sessions focus on the foods necessary for a healthy diet, how to meet nutritional needs, how to incorporate healthy exercise, and support for making these changes. For participants ages 10-15 years, patients/guardians attend the sessions. For patients ages 16 and up, the therapy is individual.
CBT-AR is a four-stage modular treatment for ARFID delivered by a mental health clinician. The four stages include: 1) Psychoeducation and early change; 2) Treatment planning; 3) Addressing maintaining mechanisms; and 4) Relapse prevention. For participants ages 10-15 years, patients/guardians attend the sessions. For patients ages 16 and up, the therapy is individual.
Eligibility Criteria
You may qualify if:
- Males and Females ages 10-18 years old
- Current ARFID
- Normal TSH or free T4 levels to rule out thyroid disease as cause of symptoms
- Negative celiac screening panel indicating no active celiac disease as cause of symptoms
- Fluency and literacy in English
You may not qualify if:
- BMI \< 5th percentile for sex and age
- Pregnancy, breastfeeding, or recent initiation/cessation of oral contraceptive pills within 8 weeks of the pre-treatment study visit
- Current/history of psychosis
- Substance/alcohol use disorder (active within the past month)
- Medical instability requiring inpatient care according to the American Psychiatric Association 2023 treatment guidelines for eating disorders
- Laboratory abnormalities indicating a need for higher level of care
- Complete lack of oral intake (suggesting a need for inpatient care)
- Tube feeding (suggesting a need for tube weaning)
- Active suicidal/homicidal ideation with intent or plan
- Contraindications to MRI
- History of major gastrointestinal tract surgery or serious medical condition (e.g., cancer)
- Medical history of intellectual disability
- Illiteracy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eating Disorders Clinical and Research Program
Boston, Massachusetts, 02139, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Eating Disorder Clinical and Research Program (EDCRP) Co-Director/Associate Professor of Psychiatry
Study Record Dates
First Submitted
July 5, 2023
First Posted
July 20, 2023
Study Start
January 31, 2024
Primary Completion
March 27, 2026
Study Completion
March 27, 2026
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
The investigators will upload de-identified data to the NIMH National Data Archive at the conclusion of the study